Month: January 2022

Southfield, Michigan , Jan. 31, 2022 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) today announced consolidated net income of $217.6 million, or $14.60 per diluted share, for the three months ended December 31, 2021 compared to consolidated net income of $166.3 million, or $9.43 per diluted share, for the same period in 2020. For the year ended December 31, 2021, consolidated net income was $958.3 million, or $59.52 per diluted share, compared to consolidated net income of $421.0 million, or $23.47 per diluted share, for the same period in 2020. Adjusted net income, a non-GAAP financial measure, for the three months ended December 31, 2021 was $212.6 million, or $14.26 per diluted share, compared to $189.5 million, or $10.75 per diluted...

WOBURN, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) — Replimune Group Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel class of tumor-directed oncolytic immunotherapies, today announced Otello Stampacchia, Ph.D., of Omega Funds, has resigned from the company’s Board of Directors. Dr. Stampacchia joined the Replimune Board in 2015, concurrent with Omega co-leading Replimune’s seed financing. Dr. Stampacchia has resigned to focus his efforts on his growing commitments at Omega and its many portfolio companies. “I would personally like to thank Otello for his numerous contributions to Replimune’s Board of Directors as we have grown from concept to a late-stage development company” said Philip Astley-Sparke, Chief Executive Officer of Replimune. “We are grateful for his service and I am joined...

– Company to prioritize industry-leading clinical-stage programs, AXO-AAV-GM1 and AXO-AAV-GM2, the first potential disease-modifying therapies for GM1 gangliosidosis and Tay-Sachs/Sandhoff disease, respectively; and to terminate AXO-Lenti-PD license agreement with Oxford Biomedica for Parkinson’s disease – Portfolio prioritization allows company to focus resources and extends estimated cash runway into the second half of 2023 – David Nassif, current CFO and General Counsel of Sio, appointed interim CEO following resignation of current CEO and Board Director Dr. Pavan Cheruvu NEW YORK and DURHAM, N.C., Jan. 31, 2022 (GLOBE NEWSWIRE) — Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases, today provided a...

SANTA CLARA, Calif., Jan. 31, 2022 (GLOBE NEWSWIRE) — Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16, 2022 at 3:40 p.m. Eastern Time. A live audio webcast and replay of the presentation may be accessed through the “Recent Events” section of Minerva’s website at http://ir.minervasurgical.com. ABOUT MINERVA SURGICAL – THE UTERINE HEALTH COMPANY Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The company has established a broad product line of commercially available,...

SAN DIEGO, Jan. 31, 2022 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with two novel technology platforms designed to provide relief for those suffering with severe pain while protecting against abuse and overdose, announced today the Company has engaged international investor relations specialists MZ Group (“MZ”) to lead a comprehensive strategic investor relations and financial communications program across all key markets. MZ Group will work closely with Ensysce management to develop and implement a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment community. The campaign will highlight how Ensysce is seeking to improve the safety of prescription drugs by applying its two breakthrough,...

MALVERN, Pa., Jan. 31, 2022 (GLOBE NEWSWIRE) — Meridian Corporation (Nasdaq: MRBK) today reported:                               2021   2021   2021   2021   2020(Dollars in thousands, except per share data) 4th QTR   3rd QTR   2nd QTR   1st QTR   4th QTRIncome:                            Net income $ 7,719   $ 9,438   $ 8,258   $ 10,170   $ 8,997Diluted earnings per common share $ 1.24   $ 1.52   $ 1.33   $ 1.65   $ 1.48Pre-tax, pre-provision income (1) $ 9,671   $ 12,898   $ 10,898   $ 13,905   $ 13,040Pre-tax, pre-provision income – Bank (1) $ 6,829   $ 8,896   $ 7,811   $ 7,891   $ 6,294(1) See Non-GAAP reconciliation in the Appendix                            Christopher J. Annas, Chairman and CEO commented “Meridian’s fourth quarter revenue of $35.3 million generated earnings of $7.7...

Frank Ingrande interviewed live Monday, January 31 by Mick Bazsuly on South Florida’s Money Talk Radio Network SAN DIEGO, Jan. 31, 2022 (GLOBE NEWSWIRE) — International Land Alliance, Inc. (OTCQB:ILAL), (“ILA” or the “Company”), an international land investment and development firm utilizing proptech, announced today that an interview with its President, Frank Ingrande is now available on YouTube at https://youtu.be/KP0UrE2a3GA. The interview by Mick Bazsuly on South Florida’s Money Talk Radio Network was recorded January 31, 2022. About International Land Alliance, Inc. International Land Alliance, Inc. (OTCQB:ILAL) is an international land investment and development firm based in San Diego, California. As its core mission, the Company has embraced technology for sustainable and socially responsible solutions, in addition...

DUBLIN, Ga., Jan. 31, 2022 (GLOBE NEWSWIRE) — Morris State Bancshares, Inc. (OTCQX: MBLU) (the “Company”), the parent of Morris Bank (the “Bank”), today announced net income of $24.0 million for the year-ended December 31, 2021, representing an increase of $6.6 million, or 37.66%, compared to net income of $17.4 million for the year-ended December 31, 2020. The company also announced diluted earnings per share of $11.40 for 2021, representing a 37.35% increase over diluted earnings per share of $8.30 for 2020. Highlights of the Company’s and Bank’s performance in 2021 include the following:Growth in net interest income of $5.6 million, representing an increase of 11.52% over 2020 Organic growth in loans of $146 million, or 19.01% exclusive of PPP loans Return on average assets (Bank) of 1.96%, compared to 1.78% in 2020 Return...

Niagara Falls, NY, Jan. 31, 2022 (GLOBE NEWSWIRE) — Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging company specializing in the field of cardiac Positron Emission Tomography (“PET”) imaging systems and clinical services, is pleased to issue today the following shareholder letter below. The letter is also available on the Company’s website at: http://www.positron.com/. Positron Corporation Shareholder Letter Dear Positron Shareholders, In consideration of our announcement of the collaboration with Neusoft Medical Systems and the expansion into the PET/CT modality we are pleased to update you on key developments that set the path for the growth and success at Positron for many years to come. As many of our investors know, in 2021 Positron returned to being a full reporting company with...

AUSTIN, Texas, Jan. 31, 2022 (GLOBE NEWSWIRE) — Asure Software, Inc., (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management (“HCM”) software solutions, today announced the launch of an advanced Treasury Management System to bring world-class automation to its preparation and reconciliation of business customers’ daily cash position. “Automating the ins and outs of money movement and the reconciliation of payroll funds in our new Treasury System sets us up to take advantage of the fintech megatrends shaping the future of payroll like same-day-pay, alternate currencies, and an Asure Wallet,” said Pat Goepel, Chairman, and CEO of Asure. “We also now have more transparency into our business than ever before which allows us to make more strategic investment decisions with client funds.” Asure’s Treasury System provides...